Clinical Trials
3 trialsNCT05360381 2023-08-08
HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase 1 Unknown
NCT05957471 2023-07-24
BC3195
Biocity Biopharmaceutics Co., Ltd.
Phase 1 Unknown
NCT04128423 2021-10-19
Study of AMV564 in Subjects With Advanced Solid Tumors
Amphivena Therapeutics, Inc.
Phase 1 Unknown